An Update on Acute and Chronic Urticaria for the Primary Care Provider

References

• . O'Donnell BF, Lawlor F, Simpson J. The impact of chronic urticaria on the quality of life. Br J Dermatol. 1997;136(2):197–201
   PubMed Web of Science ®Google Scholar
• . Kaplan AP. Urticaria angioedema. In: Allergy: Principles and Practice. Adkinson NF Jr, Busse WW, ; eds. Philadelphia, PA: Mosby; 2003;1537–1558
   Google Scholar
• . Champion RH, Roberts SO, Carpenter RG, Roger JH. Urticaria and angioedema. A review of 554 patients. Br J Dermatol. 1969;81(8):588–597
   PubMed Web of Science ®Google Scholar
• . Sheikh J. Urticaria. http://emedicine.medscape.com/article/137362overview.com. Accessed December 18, 2008.
   Google Scholar
• . Kaplan AP. Urticaria and angioedema. In: Allergy: Principles and Practices. Middleton E, Reed CE, Ellis EF, eds. St. Louis, MO: Mosby-Year Book; 1998;1104–1118
   Google Scholar
• . Charlesworth EN. Urticaria and angioedema: a clinical spectrum. Ann Allergy Asthma Immunol. 1996;76(6):484–495
   PubMed Web of Science ®Google Scholar
• . Greaves M. Chronic urticaria. J Allergy Clin Immunol. 2000;105(4):664–672
   PubMed Web of Science ®Google Scholar
• . Wong RC, Fairley JA, Ellis CN. Dermographism: a review. J Am Acad Dermatol. 1984;11 (4 pt 1):643–652
   PubMedGoogle Scholar
• . Hirschmann JV, Lawlor F, English JS, Louback JB, Winkelmann RK, Greaves MW. Cholinergic urticaria. A clinical and histologic study. Arch Dermatol. 1987;123(4):462–467
   PubMedGoogle Scholar
• . Davis MD, Brewer JD. Urticarial vasculitis and hypocomplementemic urticarial vasculitis syndrome. Immunol Allergy Clin North Am. 2004;24(2):183–213
   PubMed Web of Science ®Google Scholar
• . Brodell LA, Beck LA, Saini SS. Pathophysiology of chronic urticaria. Ann Allergy Asthma Immunol. 2008;100(4):291–297
   PubMedGoogle Scholar
• . Hide M, Francis DM, Grattan CE, Hakimi J, Kochan JP, Greaves MW. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med. 1993;328(22):1599–1604
   PubMed Web of Science ®Google Scholar
• . Jacques P, Lavoie A, Bédard PM, Brunet C, Hébert J. Chronic idiopathic urticaria: profiles of skin mast cell histamine release during active disease and remission. J Allergy Clin Immunol. 1992;89(6):1139–1143
   PubMedGoogle Scholar
• . Sheikh J. Autoantibodies to the high-affinity IgE receptor in chronic urticaria: how important are they? Curr Opin Allergy Clin Immunol. 2005;5(5):403–407
   PubMed Web of Science ®Google Scholar
• . Goodman DL, McDonnell JT, Nelson HS, Vaughan TR, Weber RW. Chronic urticaria exacerbated by the anti-oxidant food preservatives, butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT). J Allergy Clin Immunol. 1990;86(4 pt 1):570–575
   PubMedGoogle Scholar
• . Zembowicz A, Mastalerz L, Setkowicz M, . Safety of cyclooxygenase 2 inhibitors and increased leukotriene synthesis in chronic idiopathic urticaria with sensitivity to nonsteroidal anti-inflammatory drugs. Arch Dermatol. 2003;139(12):1577–1582
   PubMedGoogle Scholar
• . Kaplan AP. Chronic urticaria: pathogenesis and treatment. J Allergy Clin Immunol. 2004;114(3):465–474
   PubMed Web of Science ®Google Scholar
• . Leznoff A, Josse RG, Denburg J, Dolovich J. Association of chronic urticaria and angioedema with thyroid autoimmunity. Arch Dermatol. 1983;119(8):636–640
   PubMedGoogle Scholar
• . Zweiman B, Valenzano M, Atkins PC, Tanus T, Getsy JA. Characteristics of histamine-releasing activity in the sera of patients with chronic idiopathic urticaria. J Allergy Clin Immunol. 1996;98(1):89–98
   PubMedGoogle Scholar
• . Sabroe RA, Poon E, Orchard GE, . Cutaneous inflammatory cell infiltrate in chronic idiopathic urticaria: comparison of patients with and without anti-Fcepsilon RI or anti-IgE autoantibodies. J Allergy Clin Immunol. 1999;103(3 pt 1):484–493
   PubMedGoogle Scholar
• . Ying S, Kikuchi Y, Meng Q, Kay AB, Kaplan AP. TH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction. J Allergy Clin Immunol. 2002;109(4):694–700
   PubMed Web of Science ®Google Scholar
• . Sabroe RA, Grattan CE, Francis DM, Barr RM, Kobza Black A, Greaves MW. The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria. Br J Dermatol. 1999;140(3): 446–452
   PubMedGoogle Scholar
• . Grattan CE, Wallington TB, Warin RP, Kennedy CT, Bradfield JW. A serological mediator in chronic idiopathic urticaria—a clinical, immunological and histological evaluation. Br J Dermatol. 1986;114(5):583–590
   PubMedGoogle Scholar
• . Nguyen L, Sheikh J, Lin CK, . Serial basophil histamine release correlates with the clinical course in a patient with autoimmune urticaria. J Allergy Clin Immunol. 2000;104:S40–S41
   Google Scholar
• . Grattan CE, Francis DM, Hide M, Greaves MW. Detection of circulating histamine releasing autoantibodies with functional properties of anti-IgE in chronic urticaria. Clin Exp Allergy. 1991;21(6):695–704
   PubMed Web of Science ®Google Scholar
• . Sabroe RA, Francis DM, Barr RM, Black AK, Greaves MW. Anti-Fc(epsilon)RI auto antibodies and basophil histamine releasability in chronic idiopathic urticaria. J Allergy Clin Immunol. 1998;102(4 pt 1): 651–658
   PubMedGoogle Scholar
• . Ferrer M, Kinét JP, Kaplan AP. Comparative studies of functional and binding assays for IgG anti-Fc(epsilon)RIalpha (alpha-subunit) in chronic urticaria. J Allergy Clin Immunol. 1998;101(5):672–676
   PubMedGoogle Scholar
• . Tong LJ, Balakrishnan G, Kochan JP, Kinét JP, Kaplan AP. Assessment of autoimmunity in patients with chronic urticaria. J Allergy Clin Immunol. 1997;99(4):461–465
   PubMedGoogle Scholar
• . Asero R, Lorini M, Chong SU, Zuberbier T, Tedeschi A. Assessment of histamine releasing activity of sera from patients with chronic urticaria showing positive autologous skin test on human basophils and mast cells. Clin Exp Allergy. 2004;34(7):1111–1114
   PubMedGoogle Scholar
• . Mari A. Allergy-like asthma and rhinitis: a cross-sectional survey of a respiratory cohort and a diagnostic approach using the autologous serum skin test. Int Arch Allergy Immunol. 2004;133(1):29–39
   PubMedGoogle Scholar
• . Guttman-Yassky E, Bergman R, . The autologous serum skin test in a cohort of chronic idiopathic urticaria patients compared to respiratory allergy patients and healthy individuals. J Eur Acad Dermatol Venereol. 2007;21(1):35–39
   PubMed Web of Science ®Google Scholar
• . Vasagar K, Vonakis BM, Gober L, Viksman A, Gibbons SP Jr, Saini SS. Evidence of in vivo basophil activation in chronic idiopathic urticaria. Clin Exp Allergy. 2006;36(6):770–776
   PubMedGoogle Scholar
• . Soundararajan S, Kikuchi Y, Joseph K, Kaplan AP. Functional assessment of pathogenic IgG subclasses in chronic autoimmune urticaria. J Allergy Clin Immunol. 2005;115(4):815–821
   PubMedGoogle Scholar
• . Kikuchi Y, Kaplan AP. Mechanisms of autoimmune activation of basophils in chronic urticaria. J Allergy Clin Immunol. 2001;107(6):1056–1062
   PubMed Web of Science ®Google Scholar
• . Yasnowsky KM, Dreskin SC, Efaw B, . Chronic urticaria sera increase basophil CD203c expression. J Allergy Clin Immunol. 2006;117(6):1430–1434
   PubMedGoogle Scholar
• . Sheikh J. Effect of omalizumab on patients with chronic urticaria: issues with the determination of autoimmune urticaria. Ann Allergy Asthma Immunol. 2008;100(1):88
   PubMedGoogle Scholar
• . Saini S, Vasagar K, Huang F, Gibbons S, Vonakis BM. Signaling defects in basophils in chronic urticaria. J Allergy Clin Immunol. 2003;111:S178
   Google Scholar
• . Grattan CE, Walpole D, Francis DM, . Flow cytometric analysis of basophil numbers in chronic urticaria: basophilia is related to serum histamine releasing activity. Clin Exp Allergy. 1997;27(12):1417–1424
   PubMedGoogle Scholar
• . Wanderer AA. Cold urticaria syndromes: historical background, diagnostic classification, clinical and laboratory characteristics, pathogenesis, and management. J Allergy Clin Immunol. 1990;85(6):965–981
   PubMed Web of Science ®Google Scholar
• . Amar SM, Dreskin SC. Urticaria. Prim Care. 2008;35(1):141–157
   PubMed Web of Science ®Google Scholar
• . Irinyi B, Széles G, Gyimesi E, . Clinical and laboratory examinations in the subgroups of chronic urticaria. Int Arch Allergy Immunol. 2007;144(3):217–225
   PubMedGoogle Scholar
• . Rumbyrt JS, Katz JL, Schocket AL. Resolution of chronic urticaria in patients with thyroid autoimmunity. J Allergy Clin Immunol. 1995;96(6 pt 1):901–905
   PubMedGoogle Scholar
• . Leznoff A, Sussman GL. Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patients. J Allergy Clin Immunol. 1989;84(1):66–71
   PubMed Web of Science ®Google Scholar
• . Joint Task Force on Practice Parameters. The diagnosis and management of urticaria: a practice parameter part I: acute urticaria/angioedema part II: chronic urticaria/angioedema. Ann Allergy Asthma Immunol. 2000;85(6 pt 2):521–544
   PubMedGoogle Scholar
• . Mullins RJ, Heddle R. Adverse reactions associated with echinacea: the Australian experience. Ann Allergy Asthma Immunol. 2002;88(1):42–51
   PubMed Web of Science ®Google Scholar
• . Dibbern DA Jr. Urticaria: selected highlights and recent advances. Med Clin North Am. 2006;90(1):187–209
   PubMedGoogle Scholar
• . Knight TE, Hausen BM. Melaleuca oil (tea tree oil) dermatitis. J Am Acad Dermatol. 1994;30(3):423–427
   PubMed Web of Science ®Google Scholar
• . Wong JT, Nagy CS, Krinzman SJ, . Rapid oral challenge-desensitization for patients with aspirin-related urticaria-angioedema. J Allergy Clin Immunol. 2000;105(5):997–1001
   PubMed Web of Science ®Google Scholar
• . Grattan CE. Aspirin sensitivity and urticaria. Clin Exp Dermatol. 2003;28(2):123–127
   PubMedGoogle Scholar
• . Shertzer CL, Lookingbill DP. Effects of relaxation therapy and hypnotizability in chronic urticaria. Arch Dermatol. 1987;123(7):913–916
   PubMedGoogle Scholar
• . Kalivas J, Breneman D, Tharp M, Bruce S, Bigby M. Urticaria: clinical efficacy of cetirizine in comparison with hydroxyzine and placebo. J Allergy Clin Immunol. 1990;86(6 pt 2):1014–1018
   PubMed Web of Science ®Google Scholar
• . Breneman DL. Cetirizine versus hydroxyzine and placebo in chronic idiopathic urticaria. Ann Pharmacother. 1996;30(10):1075–1079
   PubMed Web of Science ®Google Scholar
• . Breneman D, Bronsky EA, Bruce S, . Cetirizine and astemizole therapy for chronic idiopathic urticaria: a double-blind, placebo-controlled, comparative trial. J Am Acad Dermatol. 1995;33(2 pt 1):192–198
   PubMedGoogle Scholar
• . Harto A, Sendagorta E, Ledo A. Doxepin in the treatment of chronic urticaria. Dermatologica. 1985;170(2):90–93
   PubMedGoogle Scholar
• . Goldsobel AB, Rohr AS, Siegel SC, . Efficacy of doxepin in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol. 1986;78(5 pt 1):867–873
   PubMed Web of Science ®Google Scholar
• . Monroe EW, Cohen SH, Kalbfleisch J, Schulz CI. Combined H1 and H2 antihistamine therapy in chronic urticaria. Arch Dermatol. 1981;117:404–407
   PubMed Web of Science ®Google Scholar
• . Harvey RP, Wegs J, Schocket AL. A controlled trial of therapy in chronic urticaria. J Allergy Clin Immunol. 1981;68(4):262–266
   PubMedGoogle Scholar
• . Bleehen SS, Thomas SE, Greaves MW, . Cimetidine and chlorpheniramine in the treatment of chronic idiopathic urticaria: a multi-center randomized double-blind study. Br J Dermatol. 1987;117(1):81–88
   PubMedGoogle Scholar
• . Cook LJ, Shuster S. Lack of effect of cimetidine in chronic-idiopathic urticaria. Acta Derm Venereol. 1983;63(3):265–267
   PubMedGoogle Scholar
• . Kaplan AP. Clinical practice: Chronic urticaria and angioedema. N Engl J Med. 2002;346(3):175–179
   PubMedGoogle Scholar
• . O'Donnell BF, Barr RM, Black AK, . Intravenous immunoglobulin in autoimmune chronic urticaria. Br J Dermatol. 1998;138(1):101–106
   PubMed Web of Science ®Google Scholar
• . Grattan CE, Francis DM, Slater NG, Barlow RJ, Greaves MW. Plasmapheresis for severe unremitting chronic urticaria. Lancet. 1992;339(8801):1078–1080
   PubMedGoogle Scholar
• . Toubi E, Blant A, Kessel A, Golan TD. Low-dose cyclosporin in the treatment of severe chronic idiopathic urticaria. Allergy. 1997;52(3):312–316
   PubMedGoogle Scholar
• . Werni R, Schwarz T, Gschnait F. Colchicine treatment of urticarial vasculitis. Dermatologica. 1986;172(1):36–40
   PubMedGoogle Scholar
• . Ruzicka T, Goerz G. Systemic lupus erythematosus and vasculitic urticaria. Effect of dapsone and complement levels. Dermatologica. 1981;162(3):203–205
   PubMedGoogle Scholar
• . Nettis E, Dambra P, D'Oronzio L, Loria MP, Ferrannini A, Tursi A. Comparison of montelukast and fexofenadine for chronic idiopathic urticaria. Arch Dermatol. 2001;137(1):99–100
   PubMedGoogle Scholar
• . Asero R, Tedeschi A, Lorini M. Leukotrience receptor antagonist in chronic urticaria. Allergy. 2001;56(5):456–457
   PubMedGoogle Scholar
• . Gober LM, Sterba PM, Eckman JA, Saini SS. Effect of anti-IgE (omalizumab) in chronic idiopathic urticaria (CIU) patients. J Allergy Clin Immunol. 2008;121. Abstract 566.
   Google Scholar